Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 trial evaluating romiplostim for thrombocytopenia in patients with low- or intermediate-1 risk myelodysplastic syndrome has complete…
-
CLINICAL_TRIALS research · 2013-08-12Clinical Trial Update: Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant
This document provides an update on a clinical trial studying blood samples from young patients with cytopenia after a donor stem cell trans…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies
The trial evaluating reduced-intensity umbilical cord blood transplantation in adults with advanced hematopoietic malignancies has been term…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders
This clinical trial update notes the completion of an unrelated donor stem cell transplantation study in adults with hematopoietic disorders…
-
CLINICAL_TRIALS trial_result · 2013-08-01Clinical Trial Update: Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome [Phase 2]
This is a Phase 2 clinical trial update reporting results for lenalidomide (Revlimid) in patients with acute myeloid leukemia and myelodyspl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-24Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update evaluating donor stem cell transplant for hematologic cancers, including leukemia and lymphoma, with results p…
-
CLINICAL_TRIALS trial_result · 2013-07-22Clinical Trial Update: Low Dose Melphalan and Bortezomib for AML and High-Risk MDS [NA]
Clinical trial of low-dose melphalan and bortezomib for acute myeloid leukemia and high-risk myelodysplastic syndromes has completed with re…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia [Phase 2]
Phase 2 study of VNP40101M in acute myeloid leukemia and high-risk myelodysplastic syndromes has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: 3-AP and Cytarabine in Treating Patients With Hematologic Cancer [Phase 1]
The document reports the completion of a Phase 1 trial evaluating 3-AP with cytarabine in patients with leukemia and myelodysplastic syndrom…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies [Phase 1]
Phase 1 trial of VNP40101M in combination with Cytarabine for hematologic malignancies (leukemia and myelodysplastic syndromes) has complete…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome [Phase 1]
Phase 1 trial evaluating VNP40101M in relapsed or refractory leukemia or myelodysplastic syndromes; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS [Phase 2]
Phase 2 clinical trial evaluating the combination of clofarabine and cytarabine (Ara-C) for relapsed acute myeloid leukemia and untreated my…
-
CLINICAL_TRIALS trial_result · 2013-07-15Clinical Trial Update: Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS) [NA]
Clinical trial update evaluating long-term dosing safety of romiplostim (AMG 531) in thrombocytopenic subjects with myelodysplastic syndrome…
-
FDA approval · 2013-07-11FDA Approved: DECITABINE — Original Application (Dr. Reddy's Laboratories Inc.)
This FDA page announces the approval of Dr. Reddy's Laboratories' generic decitabine under an Original Application, making a generic version…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease [Phase 1]
Phase 1 clinical trial evaluating infusion of genetically modified T cells in post-transplant patients with relapsed disease has completed. …
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome [Phase 2]
A phase 2 study of cediranib maleate in adults with relapsed/refractory or untreated acute myeloid leukemia or high-risk myelodysplastic syn…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation [Phase 2, Phase 3]
This document summarizes Phase 2 and Phase 3 clinical trials evaluating a treatment aimed at preventing graft-versus-host disease in patient…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 2]
This entry updates a Phase 2 chemotherapy trial for newly diagnosed acute myeloid leukemia, chronic myeloid leukemia, and myelodysplastic sy…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Decitabine, Cytarabine, GCSF for Refractory AML/MDS [Phase 2]
Phase 2 trial of decitabine, cytarabine, and GCSF for refractory AML/MDS was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 trial update evaluating the combination of chemotherapy and bone marrow transplantation in patients with leukemia or myelodysplastic…
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome [Phase 3]
A Phase 3 clinical trial evaluating chemotherapy in children with Down syndrome and myelodysplastic/myeloproliferative disorders, acute myel…
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) [Phase 4]
This Phase 4 clinical trial update evaluates the safety and efficacy of busulfan as a conditioning regimen prior to hematopoietic cell trans…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial evaluating the combination of thalidomide and epoetin alfa for treating anemia in patients with myelodysplastic syndr…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Decitabine in Treating Patients With Myelodysplastic Syndrome [Phase 2]
A Phase 2 clinical trial evaluating decitabine for myelodysplastic syndromes (also listed for leukemia) has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial comparing combination chemotherapy followed by peripheral stem cell transplantation versus isotretinoin in patien…